Allarity Therapeutics, Inc. – NASDAQ:ALLR
Allarity Therapeutics stock price today
Allarity Therapeutics stock price monthly change
Allarity Therapeutics stock price quarterly change
Allarity Therapeutics stock price yearly change
Allarity Therapeutics key metrics
Market Cap | 4.47M |
Enterprise value | 1.71M |
P/E | -0.02 |
EV/Sales | N/A |
EV/EBITDA | -0.09 |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -31.15 |
Revenue | N/A |
EBITDA | -17.67M |
Income | -13.49M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAllarity Therapeutics stock price history
Allarity Therapeutics stock forecast
Allarity Therapeutics financial statements
| Jun 2023 | 0 | -2.38M | |
|---|---|---|---|
| Sep 2023 | 0 | -5.55M | |
| Dec 2023 | 112K | -1.72M | -1537.5% |
| Mar 2024 | 0 | -3.84M |
| 2027 | 85.86M | -1.67M | -1.95% |
|---|
Analysts Price target
Financials & Ratios estimates
| 2023-05-11 | -7.88 | -177.2 |
|---|---|---|
| 2023-08-14 | -11.19 | -26.28 |
| 2023-11-14 | -8.17 | -2.24 |
| Jun 2023 | 13426000 | 14.14M | 105.39% |
|---|---|---|---|
| Sep 2023 | 13875000 | 17.25M | 124.35% |
| Dec 2023 | 11862000 | 14.61M | 123.19% |
| Mar 2024 | 11969000 | 18.44M | 154.06% |
| Jun 2023 | -2.49M | -116K | 2.86M |
|---|---|---|---|
| Sep 2023 | -5.37M | 0 | 6.45M |
| Dec 2023 | -1.67M | 116K | 522K |
| Mar 2024 | -1.48M | 0 | 1.38M |
Allarity Therapeutics alternative data
| Aug 2023 | 13 |
|---|---|
| Sep 2023 | 13 |
| Oct 2023 | 13 |
| Nov 2023 | 13 |
| Dec 2023 | 13 |
| Jan 2024 | 13 |
| Feb 2024 | 13 |
| Mar 2024 | 5 |
| Apr 2024 | 5 |
| May 2024 | 5 |
| Jun 2024 | 5 |
| Jul 2024 | 5 |
Allarity Therapeutics other data
| Insider | Compensation |
|---|---|
| Mr. Stefano R. Carchedi (1962) Chief Executive Officer, Pres & Director | $718,280 |
Dr. Marie Foegh DrSc, M.D. (1943) Chief Medical Officer | $288,000 |
Mr. Jens Erik Knudsen CPA, M.B.A. (1968) Chief Financial Officer | $250,000 |
Mr. James G. Cullem J.D. (1969) Chief Bus. Officer | $235,000 |
-
What's the price of Allarity Therapeutics stock today?
One share of Allarity Therapeutics stock can currently be purchased for approximately $0.9.
-
When is Allarity Therapeutics's next earnings date?
Unfortunately, Allarity Therapeutics's (ALLR) next earnings date is currently unknown.
-
Does Allarity Therapeutics pay dividends?
No, Allarity Therapeutics does not pay dividends.
-
How much money does Allarity Therapeutics make?
Allarity Therapeutics has a market capitalization of 4.47M. Allarity Therapeutics made a loss 11.9M US dollars in net income (profit) last year or -$2.24 on an earnings per share basis.
-
What is Allarity Therapeutics's stock symbol?
Allarity Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "ALLR".
-
What is Allarity Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Allarity Therapeutics?
Shares of Allarity Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Allarity Therapeutics's key executives?
Allarity Therapeutics's management team includes the following people:
- Mr. Stefano R. Carchedi Chief Executive Officer, Pres & Director(age: 63, pay: $718,280)
- Dr. Marie Foegh DrSc, M.D. Chief Medical Officer(age: 82, pay: $288,000)
- Mr. Jens Erik Knudsen CPA, M.B.A. Chief Financial Officer(age: 57, pay: $250,000)
- Mr. James G. Cullem J.D. Chief Bus. Officer(age: 56, pay: $235,000)
-
How many employees does Allarity Therapeutics have?
As Jul 2024, Allarity Therapeutics employs 5 workers.
-
When Allarity Therapeutics went public?
Allarity Therapeutics, Inc. is publicly traded company for more then 3 years since IPO on 21 Dec 2021.
-
What is Allarity Therapeutics's official website?
The official website for Allarity Therapeutics is allarity.com.
-
Where are Allarity Therapeutics's headquarters?
Allarity Therapeutics is headquartered at 210 Broadway, Cambridge, MA.
-
How can i contact Allarity Therapeutics?
Allarity Therapeutics's mailing address is 210 Broadway, Cambridge, MA and company can be reached via phone at +40 14264664.
Allarity Therapeutics company profile:
Allarity Therapeutics, Inc.
allarity.comNASDAQ
5
Biotechnology
Healthcare
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
Cambridge, MA 02139
CIK: 0001860657
ISIN: US0167443029
CUSIP: 016744104
